Bioactivx Secures $3 Million in Pre-Series A Funding Led by Martin Krupp and Cocoon Capital

Bioactivx raised $3 million in a pre-Series A round co-led by Martin Krupp and Cocoon Capital, bringing total funding to $4.9 million, according to KrASIA.

Bioactivx has successfully raised $3 million in a pre-Series A funding round, co-led by investor Martin Krupp and Cocoon Capital, according to KrASIA. This new injection brings the company's total funding to $4.9 million, reflecting growing investor confidence in its development.

The funding round also involved support from entities such as A*STAR, SingHealth, and ContInvest, highlighting a strong backing from both public and private sectors. Bioactivx aims to leverage these resources to advance its innovative projects and expand its market reach.

For Japanese investors, this development signals increasing activity in the Asian biotech funding landscape, an area closely watched for its potential impact on healthcare innovation and cross-border investment opportunities.

#newsroom

By Mansa Kane

Tokyo Overnight

Japan markets, decoded. Get the brief in your inbox.

No spam. Unsubscribe anytime.